The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both part of the National Institutes of Health (NIH), today announced the first three cancers that will be studied in the pilot phase of The Cancer Genome Atlas (TCGA) project. The cancers to be studied in the TCGA Pilot Project are lung, brain (glioblastoma), and ovarian. These cancers, which collectively account for more than 210,000 cancer cases each year in the United States, were selected because of the availability of biospecimen collections that met TCGA’s strict scientific, technical, and ethical requirements.
